SCHEMBL9115451

SCHEMBL9115451

CC(C)CCOC(=O)C(C)(C)CO

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
CYP19A1 P11511 1/20 0.37
ALDH1A1 P00352 3/20 0.36
PKM P14618 2/20 0.36
KDM4E B2RXH2 1/20 0.36
GAA P10253 1/20 0.36
KMT2A Q03164 1/20 0.36
TDP1 Q9NUW8 2/20 0.35
MAPK1 P28482 3/20 0.35
HSD17B10 Q99714 1/20 0.35
CYP4F2 P78329 1/20 0.34
CYP4A11 Q02928 1/20 0.34
PPARG P37231 1/20 0.33
LMNA P02545 1/20 0.33
MMP8 P22894 1/20 0.33
CHRNB2 P17787 2/20 0.32
CHRNA4 P43681 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27535281 0.85 CYP4F2 (0.38) GAAKMT2ACYP4F2CYP4A11LMNA
SCHEMBL28871526 0.84 CA12 (0.39) CA12CA1CA2CA9CYP19A1
SCHEMBL2680717 0.84 CA12 (0.39) CA12CA1CA2CA9CYP19A1
SCHEMBL26356853 0.82 CA1 (0.41) CA12CA1CA2CA9CYP19A1
SCHEMBL181384 0.82 CYP4F2 (0.39) ALDH1A1MAPK1CYP4F2CYP4A11
SCHEMBL7947102 0.81 CA1 (0.43) CA12CA1CA2CA9CYP19A1
SCHEMBL2691885 0.81 CA12 (0.43) CA12CA1CA2CA9CYP19A1
SCHEMBL11333162 0.79 CA1 (0.42) CA12CA1CA2CA9CYP19A1
SCHEMBL4676919 0.79 CA1 (0.42) CA12CA1CA2CA9CYP19A1
SCHEMBL4678707 0.79 CA1 (0.42) CA12CA1CA2CA9CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023205786-A1 DIDEHYDRO-3'-DEOXY-4'-ETHYNYLTHYMIDINES AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS ROME THERAPEUTICS, INC. (US) 2023-10-26 WO disclosed
WO-2022271880-A1 METHODS OF TREATING MEDICAL CONDITIONS AND INHIBITING LINE1 REVERSE TRANSCRIPTASE USING A SUBSTITUTED ADENINYL-PROPYLOXY PHOSPHONIC ACID OR RELATED COMPOUND ROME THERAPEUTICS, INC. (US) 2022-12-29 WO disclosed
WO-1995010790-A1 HIGH REFRACTIVE INDEX PHOTOCHROMIC OPHTHALMIC ARTICLE PPG INDUSTRIES, INC. (US) 1995-04-20 WO disclosed